Researchers Recommend Wider Distribution Of First EUA-Cleared COVID-19 Test Using Smartphone Technology

BD has EUA for Veritor At-Home COVID-19 rapid antigen test using smartphone vision technology to interpret and digitally display results. Researchers at biotech firms and medical schools measure advantages of at-home use of rapid antigen tests over quantitative real-time polymerase chain reaction tests.

Professional doctor in a smartphone giving a consultation online and checking a radiography, telemedicine and healthcare concept, blank copy space

US emergency use authorizations for at-home COVID-19 tests reached smartphone technology for the first time while researchers say increasing OTC access to rapid antigen tests is key to accelerating detections of infections.

Becton, Dickinson and Co. on 25 August announced the Food and Drug Administration issued an EUA for the BD Veritor At-Home COVID-19 rapid antigen test which uses computer vision technology...

More from In Vitro Diagnostics

More from Diagnostics